ESTRAGUARD Drug Patent Profile
✉ Email this page to a colleague
When do Estraguard patents expire, and when can generic versions of Estraguard launch?
Estraguard is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in ESTRAGUARD is dienestrol. Additional details are available on the dienestrol profile page.
Summary for ESTRAGUARD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Patent Applications: | 2,003 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ESTRAGUARD at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ESTRAGUARD
US Patents and Regulatory Information for ESTRAGUARD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solvay | ESTRAGUARD | dienestrol | CREAM;VAGINAL | 084436-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |